Alpha Family Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Alpha Family Trust’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-57,400	Closed	-$4.55M	–	128
2022 Q3	$4.55M	Hold	57,400	–	–	3.44%	11
2022 Q2	$4.26M	Hold	57,400	–	–	2.72%	13
2022 Q1	$5.16M	Hold	57,400	–	–	2.09%	14
2021 Q4	$6.43M	Hold	57,400	–	–	1.8%	12
2021 Q3	$7.22M	Buy	+57,400	New	+$7.39M	2.34%	14

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Alpha Family Trust's XBI Position: Q4 2022 in Review

Alpha Family Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2022, closing a stake of 57,400 shares — an estimated $4.55M sold.

Alpha Family Trust first reported a position in XBI in Q3 2021 and held it in 5 quarters. The position peaked at $7.22M in Q3 2021. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2022.

Alpha Family Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2022 after selling out during the quarter.
Alpha Family Trust sold 57,400 State Street SPDR S&P Biotech ETF shares in Q4 2022, an estimated $4.55M.
Alpha Family Trust first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and held it in 5 quarters.
Alpha Family Trust's State Street SPDR S&P Biotech ETF position peaked at $7.22M in Q3 2021.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2022.

Based on Alpha Family Trust's 13F filing for Q4 2022, filed 9 Feb 2023.